Clinical Trial Update: A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Benmelstobart and Anlotinib in combination with chemotherapy and thoracic radiotherapy for extensive-stage small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Benmelstobart

Snippet

Sponsor: Yayi He | Conditions: SCLC, Extensive Stage | Phase 2 | Status: NOT_YET_RECRUITING